For instance, β-glucans have been reported to prevent steatotic liver disease progression and liver ischemia, inhibit the growth of hepatocellular carcinoma (HepG2) liver cancer cells, improve liver regeneration after partial hepatectomy, and exert antitumor activity in liver cancer [49,62,63,64,65]. This evidence concerns the gene PPIB and liver cancer.